About BIT
Biotron Ltd (BIT) is tracked in the Health Care bucket; it is a clinical stage publicly listed Australian Biotechnology business based in Sydney, Australia. The company is developing and commercialising a novel small molecule approach that has the potential to treat a number of serious viral diseases. The technology targets viroporin proteins, which are key to enabling the pathogenicity of a number of viruses including hepatitis C, HIV-1, Dengue, Zika, Influenza and Respiratory Syncytial Virus (RSV).
All News for BIT
No news articles found for BIT yet.